Table I.
All PACE Patients (N =182,116) | Patients with Primary Pharmacy in the Top 5 (N =75,413) | |
---|---|---|
Age as of January 1, 2005, y | 78.8 (7.1) | 78.7 (6.9) |
Female | 147,718 (81.1%) | 61,802 (82.0%) |
White race | 168,175 (92.3%) | 67,571 (89.6%) |
Urban residence | 76,580 (42.1%) | 37,300 (49.5%) |
Population density (persons/sq mile) | 2903.0 (4940.1) | 3475.6 (5314.6) |
<500 | 76,210 (41.8%) | 25,786 (34.2%) |
500–999.99 | 29,326 (16.1%) | 12,327 (16.3%) |
1000–1499.99 | 8699 (4.8%) | 3902 (5.2%) |
≥1500 | 67,881 (37.3%) | 33,398 (44.3%) |
Chronic disease score for 2004 | 3.9 (2.7) | 3.9 (2.7) |
0 | 20,952 (11.5%) | 8714 (11.6%) |
1–3 | 66,420 (36.5%) | 27,272 (36.2%) |
≥4 | 94,744 (52.0%) | 39,427 (52.3%) |
Unique medications used in 2004 | 9.1 (5.1) | 8.9 (5.0) |
≤5 Medications | 48,570 (26.7%) | 20,656 (27.4%) |
6–9 Medications | 61,494 (33.8%) | 25,894 (34.3%) |
10–14 Medications | 46,661 (25.6%) | 19,097 (25.3%) |
≥15 Medications | 25,391 (13.9%) | 9766 (13.0%) |
Prescriptions filled in 2004 | 52.1 (31.0) | 50.9 (29.9) |
<25 Prescriptions | 34,294 (18.8%) | 14,912 (19.8%) |
25–49 Prescriptions | 63,720 (34.7%) | 26,563 (35.2%) |
49–74 Prescriptions | 45,718 (25.1%) | 18,881 (25.0%) |
≥75 Prescriptions | 38,384 (21.1%) | 15,057 (20.0%) |
Charlson comorbidity index score* in 2004 | 1.4 (1.8) | 1.2 (1.8) |
0 | 85,499 (46.9%) | 38,788 (51.4%) |
1–3 | 74,024 (40.7%) | 28,285 (37.5%) |
≥4 | 22,593 (12.4%) | 8340 (11.1%) |
Diagnosis of cardiovascular disease in 2004 | 70,697 (38.8%) | 26,912 (35.7%) |
Diagnosis of psychiatric disease in 2004 | 30,284 (16.6%) | 10,744 (14.3%) |
Diagnosis of diabetes in 2004 | 42,208 (23.2%) | 15,973 (21.2%) |
Diagnosis of cancer in 2004 | 15,953 (8.8%) | 6174 (8.2%) |
The scale can be used to predict 1-year mortality.